Other potential mechanisms by which targeting BRAF might restore the immune system include the impairment of Tregs and MDSC activity [89] and the down-modulation of the C-C chemokine ligand (CCL)-2 that is primarily involved in melanoma cell recruitment within the tumor milieu [90]. The gene discussed is BRAF; the disease is neoplasm.